Taken together, these results reveal that SF2535 efficaciously induces apoptosis through downregulating c-Myc and p-AKT pathways in primary B-ALL providing a rationale for further preclinical evaluation of PI3Kδ and BRD4 inhibition in B-ALL. The gene discussed is AKT1; the disease is acute lymphoblastic leukemia.